Literature DB >> 15488788

Familial idiopathic macular hole.

Sean C Lalin1, Stanley Chang, Harry Flynn, Manfred Von Fricken, Lucian V Del Priore.   

Abstract

PURPOSE: To report macular hole formation among siblings within four families.
DESIGN: Observational case series.
METHODS: Four families were identified who had macular holes among siblings from within three multiphysician tertiary-care referral retina practices.
RESULTS: In the first family, two sisters in their seventh decade developed Stage 2 macular holes requiring surgical intervention; two male siblings were unaffected. In a second family, three of four siblings were affected, including one brother with a Stage 4 macular hole, one sister with a Stage 3 macular hole, and a third sister with a lamellar macular hole. In a third family, two siblings (one man, one woman) developed macular holes within 1 year of each other. Three years later, the male sibling developed a macular hole in the fellow eye. In the last family, twin sisters developed macular holes (unilateral in one sister, bilateral in the other), and their deceased father may also have had bilateral macular holes.
CONCLUSIONS: The occurrence of macular holes in these four sets of siblings suggests a possible genetic component in the formation of macular holes in these individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488788     DOI: 10.1016/j.ajo.2004.06.013

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Lamellar macular hole formation following vitrectomy for rhegmatogenous retinal detachment repair.

Authors:  Tina Xirou; Andrej Kidess; Christina Kourentis; Vasiliki Xirou; Elias Feretis; Stamatina A Kabanarou
Journal:  Clin Ophthalmol       Date:  2012-04-12

2.  Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studies.

Authors:  Albert O Edwards; Sung J Lee; Brooke L Fridley; Nirubol Tosakulwong
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.